Bruce N. Brent

Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention.

This study examined the relationship between the femoral arteriotomy location and the risk of femoral access site complications after diagnostic and interventional cardiac catheterization procedures. One of the most common complication of cardiac catheterization and percutaneous coronary intervention (PCI) involves the vascular access site. The femoral approach is the most frequent site of vascular access during invasive cardiac procedures. This approach is associated with vascular complications, such as retroperitoneal bleeding, which can be life‐threatening. If angiographic predictors of retroperitoneal bleeding can be identified, this complication could be avoided. A prospective cohort of 33 patients with femoral access site complications was subgrouped based on the angiographic arteriotomy site. Concurrent patients without complications were randomly selected to form a control group. Study and control patients were compared on presenting risk factors and outcomes. Logistic regression analysis was used to identify independent predictors for femoral access site complications. Arteriotomy location above the most inferior border of the inferior epigastric artery in patients undergoing PCI was associated with 100% of all retroperitoneal bleeds (P < 0.001). Low, high middle, and high femoral arteriotomy sites were associated with 71% of all vascular access complications. The combination of these locations for the femoral arteriotomy was an independent predictor of adverse vascular access site complications beyond traditional risk factors (odds ratio = 28.7; CI = 6.73–122.40; P < 0.0001). Vascular complications occurred more frequently in patients who were of older age (72 vs. 66 years; P < 0.001). The location of the femoral arteriotomy site assessed by a femoral angiogram is predictive of life‐threatening complications. Patients undergoing PCI with an arteriotomy above the most inferior border of the inferior epigastric artery are at an increased risk for retroperitoneal bleeding. This complication may be avoided by risk‐stratifying patients prior to intervention with a femoral angiogram.

Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug‐eluting stent era—a report from the American College of Cardiology‐National Cardiovascular data registry (ACC‐NCDR)

We sought to determine how practice patterns for unprotected left main stenosis have changed with the advent of drug‐eluting stents (DES).

Aortic valve stenosis: Comparison of patients with to those without chronic congestive heart failure

Eighty-four patients with aortic valve stenosis (AS) and without other valvular or coronary artery disease were studied to investigate the pathophysiologic importance of hemodynamic and functional factors in the development of congestive heart failure (CHF). Thirty had clinical and radiographic signs of CHF. There was no significant difference between patients with and those without CHF in aortic valve index (0.26 +/- 0.09 vs 0.34 +/- 0.16 cm2/m2), mean aortic valve gradient (64 +/- 19 vs 59 +/- 25 mm Hg), left ventricular (LV) systolic pressure (201 +/- 31 vs 201 +/- 35 mm Hg), LV end-diastolic diameter (4.8 +/- 1.0 vs 4.4 +/- 0.7 cm) or posterior LV wall thickness (14.0 +/- 4.7 vs 15.0 +/- 30.0 mm). Patients with CHF had higher LV end-diastolic pressure (22 +/- 10 vs 16 +/- 7 mm Hg, p less than 0.005) and LV wall stress (370 +/- 138 vs 300 +/- 69 g/cm2, p less than 0.005) and lower cardiac index (2.0 +/- 0.5 vs 2.4 +/- 0.6 liters/min/m2, p less than 0.005) and LV ejection fraction (55 +/- 18 vs 68 +/- 13%, p less than 0.0005). An inverse linear relation (r = -0.59, p less than 0.01) was present between LV wall stress and LV ejection fraction such that as stress increased, LV ejection fraction fell. Values for both LV wall stress and LV ejection fraction overlapped considerably between the groups and, more important, only 40% of patients with CHF had a depressed LV ejection fraction.(ABSTRACT TRUNCATED AT 250 WORDS)

The Catch A Graphic Demonstration of the Value of Embolic Protection Devices

Embolic protection devices are now accepted adjuncts in the prevention of coronary embolization during percutaneous intervention of saphenous vein grafts. Efficacy has been demonstrated in clinical trials, which have shown a reduction in slow flow and myocardial necrosis.1 Approved devices rely on either balloon occlusion of the vessel, with thrombus extraction (eg, PercuSurge …